Dopamine deficiency in the cerebral cortex in Parkinson disease.
We measured the concentrations of dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid in several cortical areas from controls and parkinsonian patients. Substantial amounts of dopamine and its metabolites were detected in hippocampus and entorhinal, cingulate, and frontal cortex of controls. In parkinsonian patients the levels of dopamine and its metabolites were reduced in these neocortical areas and hippocampus. Diminution of cortical dopaminergic transmission may play a role in the mental impairment of some Parkinson patients.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D000368:Aged; D002540:Cerebral Cortex / Q000032:analysis*; D004298:Dopamine / Q000172:deficiency*; D006624:Hippocampus / Q000032:analysis; D006719:Homovanillic Acid / Q000032:analysis; D006801:Humans; D010300:Parkinson Disease / Q000378:metabolism*
D015102:3,4-Dihydroxyphenylacetic Acid; D004298:Dopamine; D006719:Homovanillic Acid